Advertisement

Zella 201: A Biomarker-Guided Phase II Study of Alvocidib Followed By Cytarabine and Mitoxantrone in MCL-1 Dependent Relapsed/Refractory Acute Myeloid Leukemia (AML)

Joshua F Zeidner, Tara L Lin, Carlos E Vigil, Andrew Dalovisio, Eunice S. Wang, Moshe Yair Levy, Mark G. Frattini, Daniel J. Lee, Pau Montesinos, Juan Miguel Miguel Bergua Burgues, Jeffrey R. Schriber, Stephen Anthony, David J. Bearss and B. Douglas Smith

Article Information

Citation 
vol. 132 no. Suppl 1 30

Print ISSN 
Online ISSN 
History 
  • Published online November 21, 2018.


Contributors 
  • Joshua F Zeidner [MD], 1Lineberger Comprehensive Cancer Center, UNC - Lineberger Comprehensive Cancer Center, Chapel Hill, NC
  • Tara L Lin [MD], 2University of Kansas, Westwood, KS
  • Carlos E Vigil [MD], 3Division of Hematology,Oncology, and Blood & Marrow Transplantation, The University of Iowa, Iowa City, IA
  • Andrew Dalovisio [MD], 4Ochsner Medical Center, New Orleans, LA
  • Eunice S. Wang [MD], 5Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY
  • Moshe Yair Levy [MD], 6Baylor University Medical Center at Dallas, Dallas, TX
  • Mark G. Frattini [MD PhD], 7Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY
  • Daniel J. Lee [MD], 8Columbia University Medical Center, New York, NY
  • Pau Montesinos [MD PhD], 98University Hospital La Fe, Valencia, Spain & CIBERONC, Instituto Carlos III, Madrid, Spain,, Valencia, Spain
  • Juan Miguel Miguel Bergua Burgues, 10Hospital San Pedro de Alacantara, Cáceres, Spain, Caceres, Spain
  • Jeffrey R. Schriber [MD], 11Scottsdale Healthcare Shea, Scottsdale, AZ
  • Stephen Anthony [DO], 12Tolero Pharmaceuticals, Inc., Lehi, UT
  • David J. Bearss [PhD], 12Tolero Pharmaceuticals, Inc., Lehi, UT
  • B. Douglas Smith [MD], 13Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD

Altmetric.com Statistics

The Altmetric score is a weighted count of online attention designed to reflect the volume and reach of online engagement surrounding an individual research output